Lewis Pharmaceuticals Private Limited

Lewis Pharmaceuticals Private Limited - pharma in Surat, Gujarat, India. FY 2026 financials & compliance.
CIN U24290GJ2020PTC112260 Incorporated 23 January 2020 ROC Ahmedabad HQ Surat, Gujarat, India
Active Private Limited Company pharma Startup India
Revenue · FY 2025
₹7.09 Cr
▲ 9% YoY
Net profit · FY 2025
₹49.47 Lakh
Net margin 7%
EBITDA · FY 2025
₹76.93 Lakh
EBITDA margin 10.9%
Authorised capital
₹15 Lakh
Registered with MCA
Paid-up capital
₹15 Lakh
Issued & subscribed
Open charges
₹99.5 Lakh
Satisfied ₹1.5 Cr
Company age
6 yrs
Est. 2020
Directors on board
2
As per MCA filings

About Lewis Pharmaceuticals Private Limited

Data last updated:

Lewis Pharmaceuticals Private Limited is a private limited company based in Surat, Gujarat, India, recognised as a startup by DPIIT. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 23 January 2020 and has been in existence for over 6 years.

The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24290GJ2020PTC112260. Its GSTIN is 24AAECL1468Q1Z2 (Gujarat).

The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹15 Lakh. It is led by directors Jignesh Karsanbhai Solanki and Umang Rajendrakumar Patel.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. 13 Bhagvati Park Society Honey Park Road Adajan, Surat, Gujarat, India – 395007.

As per the financials filed for FY 2025, the company reported a revenue of ₹7.09 Cr, a growth of 9% compared to the previous year. For the same year it recorded a net profit of ₹49.47 Lakh (net margin 7%) and EBITDA of ₹76.93 Lakh (EBITDA margin 10.9%). Revenue has grown at a compounded annual rate (CAGR) of 32% over three years.

As per MCA filings, the company has open charges of ₹99.5 Lakh and satisfied charges of ₹1.5 Cr on record.

Company details

CIN U24290GJ2020PTC112260
Registration Number 112260
Incorporation Date 23 January 2020
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
DPIIT Recognition Recognised Startup
Key People
Jignesh Karsanbhai Solanki Director Umang Rajendrakumar Patel Director

Recognitions & Rankings of Lewis Pharmaceuticals

Startup India Government of India

Contact details

Lewis Pharmaceuticals Private Limited's registered office is in Surat, Gujarat. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Plot No. 13 Bhagvati Park Society Honey Park Road Adajan, Surat, Gujarat, India – 395007
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Lewis Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Lewis Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Lewis Pharmaceuticals is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Lewis Pharmaceuticals Private Limited, buy the company report.

Financials of Lewis Pharmaceuticals Private Limited

FY 2025 filings available

Lewis Pharmaceuticals Private Limited reported revenue of ₹7.09 Cr (up 9% YoY) for FY 2025.

Revenue · FY 2025
₹7.09 Cr ▲ 9%
Net profit · FY 2025
₹49.47 Lakh margin 7%
EBITDA · FY 2025
₹76.93 Lakh margin 10.9%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 9%
3 years · compounded
▲ 32%
EBITDA CAGR growth
1 year
▲ 5%
3 years · compounded
▲ 51%

Revenue has grown at a compounded annual rate (CAGR) of 32% over three years, including 9% growth in the latest year. EBITDA rose 5% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹76.93 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹49.47 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin10.9%
Net Profit Margin7%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Lewis Pharmaceuticals Private Limited, buy the company report.

Board of directors of Lewis Pharmaceuticals Private Limited

Lewis Pharmaceuticals has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Jignesh Karsanbhai Solanki
Also directs: Lewis Pharmaceuticals Export Private Limited, Lewis Renewable Energy Park Private Limited, Lewis Energy Solutions Private Limited and 3 more
Director23 Jan 20206 Years 9 MonthsCurrent
Umang Rajendrakumar Patel
Also directs: Lewis Pharmaceuticals Export Private Limited
Director23 Jan 20206 Years 9 MonthsCurrent
View all directors

Peer comparison

Lewis Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Priority Pharmaceuticals Private Limited₹7.12 Cr (FY 2025)174.0%Jaipur, Rajasthan, India
Benmed Pharma Private Limited₹7.11 Cr (FY 2024)59.0%Ambala, Haryana, India
Gladje Pharmaceuticals Private Limited₹7.09 Cr (FY 2025)94.0%Jaipur, Rajasthan, India
Lewis Pharmaceuticals Private Limitedthis company₹7.09 Cr (FY 2025)₹49.47 Lakh7%9.0%Surat, Gujarat, India
Bell Pharmaceuticals and Cosmetics Private Limited₹7.09 Cr (FY 2025)142.0%Hyderabad, Telangana, India
Ampira Biotechnics Private Limited₹7.07 Cr (FY 2024)5.0%Manimajra, Chandigarh, India

To see the full peer comparison of Lewis Pharmaceuticals Private Limited, buy the company report.

Auditor

Lewis Pharmaceuticals Private Limited is audited by C H R AND CO. for the financial year 2023.

Auditor firmFinancial yearFirm registration number
C H R AND CO.FY 20230149135W

Shareholding

The shareholding of Lewis Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Lewis Pharmaceuticals Private Limited, buy the company report.

Charges & borrowings

Open charges
₹99.5 Lakh
Satisfied charges
₹1.5 Cr
Breakdown by lending institutions
Axis Bank Limited₹1.00 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
18 Jun 2025101118650Axis Bank Limited₹99.5 LakhOpen
27 Jan 2024100865931Axis Bank Limited₹1.5 CrSatisfied

To see the full charge records of Lewis Pharmaceuticals Private Limited, buy the company report.

Total charge records: 2 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Lewis Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Lewis Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
24AAECL1468Q1Z2GujaratActive07 Mar 2020

To see the full GST registrations and return filing status of Lewis Pharmaceuticals Private Limited, buy the company report.

Recent activity

Lewis Pharmaceuticals Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Jignesh Karsanbhai Solanki was appointed as Director on 23 Jan 2020.

AGM
Lewis Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Axis Bank Limited amounted to Rs. 99.50 Lakh with Charge ID 101118650 was registered on 18 Jun 2025.
Filing
Lewis Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Charges
A charge registered on 27 Jan 2024 via Charge ID 100865931 with Axis Bank Limited was fully satisfied on 05 Mar 2025.
Charges
A charge with Axis Bank Limited amounted to Rs. 150.00 Lakh with Charge ID 100865931 was registered on 27 Jan 2024.
Appointed
Jignesh Karsanbhai Solanki was appointed as Director.
Appointed
Umang Rajendrakumar Patel was appointed as Director.
Incorporation
23 Jan 2020
Lewis Pharmaceuticals Private Limited was registered on 23 Jan 2020 with Roc Ahmedabad & aged 6 years 9 months as per MCA records.

Frequently asked questions

Lewis Pharmaceuticals is an active private limited company based in Surat, Gujarat, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 23 January 2020 (6+ years old) and is registered under CIN U24290GJ2020PTC112260.

Lewis Pharmaceuticals has 2 current directors:

The latest financial statements of Lewis Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.

The GSTIN of Lewis Pharmaceuticals is 24AAECL1468Q1Z2, registered in Gujarat.

The CIN (Corporate Identification Number) of Lewis Pharmaceuticals is U24290GJ2020PTC112260. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Lewis Pharmaceuticals was incorporated on 23 January 2020, making it 6+ years old. It is registered with the Registrar of Companies, Ahmedabad.

The peers of Lewis Pharmaceuticals by revenue are Priority Pharmaceuticals Private Limited, Benmed Pharma Private Limited, Gladje Pharmaceuticals Private Limited, Bell Pharmaceuticals and Cosmetics Private Limited, Ampira Biotechnics Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).

Jignesh Karsanbhai Solanki was appointed as Director on 23 Jan 2020. Umang Rajendrakumar Patel was appointed as Director on 23 Jan 2020.

Yes, Lewis Pharmaceuticals is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).

The registered office of Lewis Pharmaceuticals is at Plot No. 13 Bhagvati Park Society Honey Park Road Adajan, Surat, Gujarat, India – 395007.

Lewis Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.